Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
Borella G, Da Ros A, Borile G, Porcù E, Tregnago C, Benetton M, Marchetti A, Bisio V, Montini B, Michielotto B, Cani A, Leszl A, Campodoni E, Sandri M, Montesi M, Bresolin S, Cairo S, Buldini B, Locatelli F, Pigazzi M. Borella G, et al. Among authors: bisio v. Blood. 2021 Aug 19;138(7):557-570. doi: 10.1182/blood.2020009845. Blood. 2021. PMID: 34010415 Free article.
Core-binding factor acute myeloid leukemia in pediatric patients enrolled in the AIEOP AML 2002/01 trial: screening and prognostic impact of c-KIT mutations.
Manara E, Bisio V, Masetti R, Beqiri V, Rondelli R, Menna G, Micalizzi C, Santoro N, Locatelli F, Basso G, Pigazzi M. Manara E, et al. Among authors: bisio v. Leukemia. 2014 May;28(5):1132-4. doi: 10.1038/leu.2013.339. Epub 2013 Nov 14. Leukemia. 2014. PMID: 24226631 Clinical Trial. No abstract available.
Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement.
Pigazzi M, Manara E, Buldini B, Beqiri V, Bisio V, Tregnago C, Rondelli R, Masetti R, Putti MC, Fagioli F, Rizzari C, Pession A, Locatelli F, Basso G. Pigazzi M, et al. Among authors: bisio v. Haematologica. 2015 Mar;100(3):e99-101. doi: 10.3324/haematol.2014.114579. Epub 2014 Dec 5. Haematologica. 2015. PMID: 25480496 Free PMC article. No abstract available.
CREB engages C/EBPδ to initiate leukemogenesis.
Tregnago C, Manara E, Zampini M, Bisio V, Borga C, Bresolin S, Aveic S, Germano G, Basso G, Pigazzi M. Tregnago C, et al. Among authors: bisio v. Leukemia. 2016 Sep;30(9):1887-96. doi: 10.1038/leu.2016.98. Epub 2016 Apr 27. Leukemia. 2016. PMID: 27118402
NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group.
Bisio V, Zampini M, Tregnago C, Manara E, Salsi V, Di Meglio A, Masetti R, Togni M, Di Giacomo D, Minuzzo S, Leszl A, Zappavigna V, Rondelli R, Mecucci C, Pession A, Locatelli F, Basso G, Pigazzi M. Bisio V, et al. Leukemia. 2017 Apr;31(4):974-977. doi: 10.1038/leu.2016.361. Epub 2016 Nov 28. Leukemia. 2017. PMID: 27890935 No abstract available.
A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia.
Zampini M, Bisio V, Leszl A, Putti MC, Menna G, Rizzari C, Pession A, Locatelli F, Basso G, Tregnago C, Pigazzi M. Zampini M, et al. Among authors: bisio v. Br J Haematol. 2018 Oct;183(2):298-301. doi: 10.1111/bjh.14950. Epub 2017 Sep 29. Br J Haematol. 2018. PMID: 28961307 Free article. No abstract available.
24 results